Dissecting the earnings of AMD and Intel and excuses made by management, with Mad Money host Jim Cramer.» Read More
UBS threatened to scale back its presence in London if the government followed advice from a heritage body that effectively blocked the redevelopment of its City of London headquarters, reported the FT.
See what's happening, who's talking and what will be making headlines on Thursday's Squawk on the Street.
Simon Rutherfurd, Portfolio Manager at Northwest Capital, is currently overweight on Rio and believes that it is a very good buy at these levels.
Chen Wai Yee, Head of Derivatives - Asian Desk at RBS Morgans, believes in Rio's diversified business and strong cashflow.
Ed Ponsi, Managing Director at Barchetta Capital Management, says the effects of yen intervention and the increase of Swiss interest rate will not last because of the tremendous of pressure to sell the U.S. dollar.
Sani Hamid, Director, Wealth Management, Economy & Market Strategy at Financial Alliance, expects more currency intervention across Asia.
Jaideep Panwar, Responsible Investment Analyst at Responsible Research, lists the major challenges in consumers adopting electric cars.
Michael Cohen, Partner, Litigation Department at Paul Hastings, says there are good opportunities in the pharmaceutical arena in Japan.
When the going gets tough, the tough go shopping. After a series of worrying economic reports, the nation's chain stores may actually tell one of the better stories about activity in the month of July.
Graham Bibby, Managing Director, CIO & CEO of Richmond Asset Management, explains why he likes Crocs, Apple, and some Internet stocks.
In a market that's up one day and down the next, strategists told CNBC Wednesday there are definitely buying opportunities—but there are also places to sell.
Discussing the market's comeback and whether stocks are undervalued, with CNBC's Seema Mody; Lee Munson, Portfolio chief investment officer; Andrew Busch, BMO Capital Markets, and Jack Bourdoudjian, Index Futures Group.
Mad Money host Jim Cramer shares his final thoughts of the day.
Mad Money host Jim Cramer explains why Allergan isn't about to fall off a patent cliff like so many other big pharma companies. David Pyott, Allergan chairman, president & CEO weighs in on the company's earnings.
Jeffrey Christian, Managing Director at CPM Group says gold prices could drop as investors weigh in on the U.S. debt deal's positive impact on sentiment.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
William O'Donnell, Head of U.S. Treasury Strategy at RBS Global Banking & Markets says thirty year bonds have underperformed recently on debt default fears.
Mad Money host Jim Cramers says the oil company's stock is ready to play catch up, thanks to the its growth potential and low costs. John Richels, Devon Energy president and CEO weighs in.
Howard Eisen, Managing Director and Co-Founder of FletcherBennett is not convinced that the ongoing market rally seen from the U.S. debt relief will last.
Mad Money host Jim Cramer says the cavalry finally came into the market today in the form of lower oil.